펩톤 시장 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 출처별, 제품별, 용도별, 최종사용자별 및 지역별
Peptone Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
상품코드:1413765
리서치사:Fairfield Market Research
발행일:2024년 01월
페이지 정보:영문 335 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 펩톤 시장 규모는 현재 1억 5,000만 달러에 이르고, 연평균 5%의 놀라운 속도로 성장하여 2031년에는 2억 500만 달러에 달할 것으로 예상됩니다. 이러한 성장의 원동력은 정형외과 질환의 유병률 증가, 임상 디지털화에 대한 수요 증가 등의 요인에 기인합니다. 동물성 펩톤은 2024년 세계 시장을 장악하며 시장 점유율의 50% 이상을 차지할 것으로 보입니다. 또한 펩톤은 세계 세포 배양 배지 시장에서도 중요한 역할을 하고 있습니다.
대형 바이오 제약사들은 시장 진입을 확대하고 수익성을 개선하기 위해 아웃소싱 모델을 채택하고 있습니다. 현지 공급업체와 장기적인 파트너십을 맺으면 운영 비용을 낮추고 가격 책정을 개선할 수 있습니다. 아시아태평양의 자원을 활용하고 현지 위탁 생산업체와 파트너십을 맺음으로써 기업은 지속 가능한 성장을 달성할 수 있습니다.
아시아, 중동 및 아프리카 국가의 정부 당국은 헬스케어 및 바이오 제약 산업의 성장을 적극적으로 장려하고 있습니다. 투자 우대 등 정부의 우호적인 정책은 기업들이 펩톤 시장에 투자할 수 있는 큰 기회를 창출하고 있습니다.
세포 배양 최적화를 위해 동물성 펩톤을 사용하면 바이러스 오염의 위험이 발생하여 배지 품질에 영향을 미칠 수 있습니다. 복잡한 의약품 승인 절차는 펩톤의 유통을 지연시킬 수 있습니다. 기업은 종종 업데이트되거나 개선된 제품을 시장에 출시하기 전에 모든 규제 당국의 승인을 기다려야 하는 경우가 많으며, 이는 성장에 방해가 됩니다.
이 보고서는 세계 펩톤 시장에 대해 조사했으며, 시장 개요와 함께 유래 유형별/제품별/용도별/최종사용자별/지역별 동향, 시장 진출기업의 경쟁 동향 등을 제공합니다.
목차
제1장 주요 요약
제2장 시장 개요
시장 정의와 세분화
시장 역학
밸류체인 분석
Porter의 Five Forces 분석
COVID-19의 영향 분석
우크라이나와 러시아 분쟁의 영향
경제 개요
PESTLE 분석
제3장 세계의 펩톤 시장 전망, 2018년-2031년
세계의 펩톤 시장 전망, 유래 유형별, 금액(100만 달러), 2018년-2031년
세계의 펩톤 시장 전망, 제품별, 금액(100만 달러), 2018년-2031년
세계의 펩톤 시장 전망, 용도별, 금액(100만 달러), 2018년-2031년
세계의 펩톤 시장 전망, 최종사용자별, 금액(100만 달러), 2018년-2031년
세계의 펩톤 시장 전망, 지역별, 금액(100만 달러), 2018년-2031년
제4장 북미의 펩톤 시장 전망, 2018년-2031년
제5장 유럽의 펩톤 시장 전망, 2018년-2031년
제6장 아시아태평양의 펩톤 시장 전망, 2018년-2031년
제7장 라틴아메리카의 펩톤 시장 전망, 2018년-2031년
제8장 중동 및 아프리카의 펩톤 시장 전망, 2018년-2031년
제9장 경쟁 구도
동맥 유형과 적응증 히트맵
제조업체와 적응증 히트맵
기업의 시장 점유율 분석, 2023년
경쟁 대시보드
기업 개요
Hi-Media Laboratories
B. Braun Melsungen AG
제10장 부록
LSH
영문 목차
영문목차
The global Peptone market is currently valued at US$ 150 million and is set to expand at an impressive compound annual growth rate (CAGR) of 5%, projecting a market valuation of US$ 205 million by the year 2031. This growth is driven by factors such as the rising prevalence of orthopedic diseases and the increasing demand for clinical digitization. Peptones, derived from animal sources, dominated the global market in 2024, accounting for over 50% of the market share. Furthermore, peptones played a vital role in the global cell culture media market.
Opportunities for Peptone Manufacturers:
Several opportunities are on the horizon for peptone manufacturers:
Contract Manufacturing in Asia Pacific: Leading biopharmaceutical players are embracing outsourcing models to expand their market reach and enhance their profitability. Long-term partnerships with local suppliers can lower operational costs and improve pricing. By capitalizing on resources in Asia Pacific and forming partnerships with local contract-based manufacturers, companies can achieve sustainable growth.
Government Support for Biopharmaceutical Industry: Government authorities in Asian and Middle Eastern & African countries are actively encouraging healthcare and biopharmaceutical industry growth. Favorable government policies, such as investment incentives, are creating significant opportunities for companies to invest in the peptone market.
Challenges Affecting Peptone Demand:
Despite the promising outlook, the peptone market faces challenges:
Risk of Virus Contamination During Cell Culture: The use of animal-derived peptones in cell culture optimization poses a risk of viral contamination, potentially affecting the quality of the media.
Regulatory Approval Complexity: The complex regulatory approval process can delay peptone distribution. Companies often need to wait for all regulatory approvals before introducing updated or improved products to the market, hindering growth.
Country-wise Insights:
How are Peptone Suppliers Strategizing in the U.S. Market?
"Expansion & Increasing Production Capacity by U.S. Companies"
The U.S. dominates the North American peptone market, holding a substantial market share.
The prevalence of life-threatening chronic diseases in the U.S. has driven its market leadership in North America. Leading players in the industry are expanding production capacity and improving their manufacturing processes, offering growth opportunities. For example, Nu-Tek BioSciences, LLC introduced the first animal-free peptone and protein hydrolysate manufacturing facility in Austin, U.S., in March 2021.
Why is the Peptone Industry Significant in Germany?
"Presence of Leading Peptone Manufacturers"
Germany holds a significant share in the European peptone market, thanks to its strong healthcare expenditure.
Germany boasts a substantial healthcare expenditure and is expected to maintain steady growth. The presence of major industry players in the country ensures the availability of peptone products, contributing to its significant market share.
Why is China Emerging as a Noteworthy Market for Peptones?
"Strategic Initiatives by Industry Players in China"
In 2023, China's peptone market held a considerable market share in East Asia.
China is actively developing its healthcare infrastructure and pursuing strategic collaborations for expansion. The presence of numerous importers, exporters, and collaborative research activities augments the growth of the peptone market in China. Furthermore, China's exports of active pharmaceutical ingredients are expected to boost the demand for peptones.
What is the Outlook for the India Peptone Market?
"Rapid Growth of the Biotechnology Industry and Research Activities"
India dominates the South Asia peptone market, with a substantial market share in 2023.
India's biotechnology sector is experiencing rapid growth, with a flourishing research environment. The country is home to thousands of biotech businesses, including core companies and startups. The biotechnology market in India is projected to continue expanding, driven by research activities.
Competitive Landscape:
Leading peptone suppliers are actively engaged in collaborative approaches, mergers, and acquisitions to expand their market presence and drive research and development efforts. Companies such as Hi-Media Laboratories, Thermo Fisher Scientific, Inc., and Merck KGaA are focused on product launches, acquisitions, and approvals to enhance their market position.
Key Companies Driving Innovation:
Hi-Media Laboratories
Thermo Fisher Scientific, Inc.
Merck KGaA
Hardy Diagnostics
Solabia Group
Kerry Inc.
Organotechnie
Biotecnica
Nu-Tek BioScience LLC
Tatua
Krishna Enzytech Pvt. Ltd.
Titan Biotech
Suvidhinath Laboratories
Jeevan Biotech
Key Segments Covered in Peptone Industry Survey
Peptone Market by Source:
Plants
Soya Peptones
Vegetable Peptones
Others
Yeast
Peptone
Extract
Animal
Beef Extract
Casein Peptones
Gelatin Peptones
Brain Heart Infusion (Bovine)
Brain Heart Infusion (Porcine)
Casein (Acid Hydrolysate)
Heart Infusion (Bovine)
Heart Infusion (Porcine)
Lactalbumin
Meat Peptone (Bovine)
Meat Peptone (Porcine)
Ox-Bile
Peptonized Milk
Polypeptone
Pork Heart Digest
Protease Peptones
Peptone Market by Product:
Protein Hydrolysates
Infusions
Extracts
Peptone Market by Application:
Microbial Cell Culture
Mammalian Cell Culture
Plant Tissue Culture
Yeast Culture
Peptone Market by End User:
Academic & Research Institutes
Biopharmaceutical Companies
Contract Research Laboratories
Peptone Market by Region:
North America Peptone Market
Latin America Peptone Market
Europe Peptone Market
South Asia Peptone Market
East Asia Peptone Market
Oceania Peptone Market
The Middle East & Africa (MEA) Peptone Market
Table of Contents
1. Executive Summary
1.1. Global Peptone Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Peptone Market Outlook, 2018 - 2031
3.1. Global Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Plants
3.1.1.1.1. Soya Peptones
3.1.1.1.2. Vegetable Peptones
3.1.1.1.3. Others
3.1.1.2. Yeast
3.1.1.2.1. Peptone
3.1.1.2.2. Extract
3.1.1.3. Animal
3.1.1.3.1. Beef Extract
3.1.1.3.2. Casein Peptones
3.1.1.3.3. Gelatin Peptones
3.1.1.3.4. Brain Heart Infusion (Bovine)
3.1.1.3.5. Brain Heart Infusion (Porcine)
3.1.1.3.6. Casein (Acid Hydrolysate)
3.1.1.3.7. Heart Infusion (Bovine)
3.1.1.3.8. Heart Infusion (Porcine)
3.1.1.3.9. Lactalbumin
3.1.1.3.10. Meat Peptone (Bovine)
3.1.1.3.11. Meat Peptone (Porcine)
3.1.1.3.12. Ox-Bile
3.1.1.3.13. Peptonized Milk
3.1.1.3.14. Polypeptone
3.1.1.3.15. Pork Heart Digest
3.1.1.3.16. Protease Peptones
3.2. Global Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Protein Hydrolysates
3.2.1.2. Infusions
3.2.1.3. Extracts
3.3. Global Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Microbial Cell Culture
3.3.1.2. Mammalian Cell Culture
3.3.1.3. Plant Tissue Culture
3.3.1.4. Yeast Culture
3.4. Global Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. Academic & Research Institutes
3.4.1.2. Biopharmaceutical Companies
3.4.1.3. Contract Research Laboratories
3.5. Global Peptone Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Peptone Market Outlook, 2018 - 2031
4.1. North America Peptone Market Outlook, by Source Type, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Plants
4.1.1.1.1. Soya Peptones
4.1.1.1.2. Vegetable Peptones
4.1.1.1.3. Others
4.1.1.2. Yeast
4.1.1.2.1. Peptone
4.1.1.2.2. Extract
4.1.1.3. Animal
4.1.1.3.1. Beef Extract
4.1.1.3.2. Casein Peptones
4.1.1.3.3. Gelatin Peptones
4.1.1.3.4. Brain Heart Infusion (Bovine)
4.1.1.3.5. Brain Heart Infusion (Porcine)
4.1.1.3.6. Casein (Acid Hydrolysate)
4.1.1.3.7. Heart Infusion (Bovine)
4.1.1.3.8. Heart Infusion (Porcine)
4.1.1.3.9. Lactalbumin
4.1.1.3.10. Meat Peptone (Bovine)
4.1.1.3.11. Meat Peptone (Porcine)
4.1.1.3.12. Ox-Bile
4.1.1.3.13. Peptonized Milk
4.1.1.3.14. Polypeptone
4.1.1.3.15. Pork Heart Digest
4.1.1.3.16. Protease Peptones
4.2. North America Peptone Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Protein Hydrolysates
4.2.1.2. Infusions
4.2.1.3. Extracts
4.3. North America Peptone Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Microbial Cell Culture
4.3.1.2. Mammalian Cell Culture
4.3.1.3. Plant Tissue Culture
4.3.1.4. Yeast Culture
4.4. North America Peptone Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. Academic & Research Institutes
4.4.1.2. Biopharmaceutical Companies
4.4.1.3. Contract Research Laboratories
4.5. North America Peptone Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.5.1. Key Highlights
4.5.1.1. U.S. Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
4.5.1.2. U.S. Peptone Market Indication, Value (US$ Mn), 2018 - 2031
4.5.1.3. U.S. Peptone Market Artery Type, Value (US$ Mn), 2018 - 2031
4.5.1.4. U.S. Peptone Market End User, Value (US$ Mn), 2018 - 2031
4.5.1.5. Canada Peptone Market by Source Type, Value (US$ Mn), 2018 - 2031
